Zoran Trogrlić1, Mathieu van der Jagt1, Hester Lingsma2, Diederik Gommers1, Huibert H Ponssen3, Jeannette F J Schoonderbeek4, Frodo Schreiner5, Serge J Verbrugge6, Servet Duran7, Jan Bakker1,8,9,10, Erwin Ista11. 1. Department of Intensive Care Adults, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands. 2. Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands. 3. Department of Intensive Care, Albert Schweitzer Hospital, Dordrecht, The Netherlands. 4. Department of Intensive Care, Ikazia Hospital, Rotterdam, The Netherlands. 5. Department of Intensive Care, IJsselland Hospital, Rotterdam, The Netherlands. 6. Department of Intensive Care, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands. 7. Department of Intensive Care, Maasstad Hospital, Rotterdam, The Netherlands. 8. Department of Pulmonology and Critical Care, New York University - Langone, New York, NY. 9. Department of Pulmonology and Critical Care, Columbia University Medical Center - New York Presbyterian, New York, NY. 10. Department of Intensive Care, Pontificia Universidad Catolica de Chile, Santiago, Chile. 11. Department of Pediatric Surgery, Intensive Care Unit, Erasmus MC - Sophia Children's Hospital University Medical Center Rotterdam, Rotterdam, The Netherlands.
Abstract
OBJECTIVES: Implementation of delirium guidelines at ICUs is suboptimal. The aim was to evaluate the impact of a tailored multifaceted implementation program of ICU delirium guidelines on processes of care and clinical outcomes and draw lessons regarding guideline implementation. DESIGN: A prospective multicenter, pre-post, intervention study. SETTING: ICUs in one university hospital and five community hospitals. PATIENTS: Consecutive medical and surgical critically ill patients were enrolled between April 1, 2012, and February 1, 2015. INTERVENTIONS: Multifaceted, three-phase (baseline, delirium screening, and guideline) implementation program of delirium guidelines in adult ICUs. MEASUREMENTS AND MAIN RESULTS: The primary outcome was adherence changes to delirium guidelines recommendations, based on the Pain, Agitation and Delirium guidelines. Secondary outcomes were brain dysfunction (delirium or coma), length of ICU stay, and hospital mortality. A total of 3,930 patients were included. Improvements after the implementation pertained to delirium screening (from 35% to 96%; p < 0.001), use of benzodiazepines for continuous sedation (from 36% to 17%; p < 0.001), light sedation of ventilated patients (from 55% to 61%; p < 0.001), physiotherapy (from 21% to 48%; p < 0.001), and early mobilization (from 10% to 19%; p < 0.001). Brain dysfunction improved: the mean delirium duration decreased from 5.6 to 3.3 days (-2.2 d; 95% CI, -3.2 to -1.3; p < 0.001), and coma days decreased from 14% to 9% (risk ratio, 0.5; 95% CI, 0.4-0.6; p < 0.001). Other clinical outcome measures, such as length of mechanical ventilation, length of ICU stay, and hospital mortality, did not change. CONCLUSIONS: This large pre-post implementation study of delirium-oriented measures based on the 2013 Pain, Agitation, and Delirium guidelines showed improved health professionals' adherence to delirium guidelines and reduced brain dysfunction. Our findings provide empirical support for the differential efficacy of the guideline bundle elements in a real-life setting and provide lessons for optimization of guideline implementation programs.
OBJECTIVES: Implementation of delirium guidelines at ICUs is suboptimal. The aim was to evaluate the impact of a tailored multifaceted implementation program of ICU delirium guidelines on processes of care and clinical outcomes and draw lessons regarding guideline implementation. DESIGN: A prospective multicenter, pre-post, intervention study. SETTING: ICUs in one university hospital and five community hospitals. PATIENTS: Consecutive medical and surgical critically illpatients were enrolled between April 1, 2012, and February 1, 2015. INTERVENTIONS: Multifaceted, three-phase (baseline, delirium screening, and guideline) implementation program of delirium guidelines in adult ICUs. MEASUREMENTS AND MAIN RESULTS: The primary outcome was adherence changes to delirium guidelines recommendations, based on the Pain, Agitation and Delirium guidelines. Secondary outcomes were brain dysfunction (delirium or coma), length of ICU stay, and hospital mortality. A total of 3,930 patients were included. Improvements after the implementation pertained to delirium screening (from 35% to 96%; p < 0.001), use of benzodiazepines for continuous sedation (from 36% to 17%; p < 0.001), light sedation of ventilated patients (from 55% to 61%; p < 0.001), physiotherapy (from 21% to 48%; p < 0.001), and early mobilization (from 10% to 19%; p < 0.001). Brain dysfunction improved: the mean delirium duration decreased from 5.6 to 3.3 days (-2.2 d; 95% CI, -3.2 to -1.3; p < 0.001), and coma days decreased from 14% to 9% (risk ratio, 0.5; 95% CI, 0.4-0.6; p < 0.001). Other clinical outcome measures, such as length of mechanical ventilation, length of ICU stay, and hospital mortality, did not change. CONCLUSIONS: This large pre-post implementation study of delirium-oriented measures based on the 2013 Pain, Agitation, and Delirium guidelines showed improved health professionals' adherence to delirium guidelines and reduced brain dysfunction. Our findings provide empirical support for the differential efficacy of the guideline bundle elements in a real-life setting and provide lessons for optimization of guideline implementation programs.
Authors: Kendra J Schomer; Jeremiah J Duby; Rachelle L Firestone; Erin L Louie; Christian M Sebat; Dawn M Love; Christine S Cocanour; Timothy E Albertson Journal: Crit Care Explor Date: 2020-03-24
Authors: Zoran Trogrlic; Mathieu van der Jagt; Theo van Achterberg; Huibert Ponssen; Jeannette Schoonderbeek; Frodo Schreiner; Serge Verbrugge; Annemieke Dijkstra; Jan Bakker; Erwin Ista Journal: BMJ Open Qual Date: 2020-09
Authors: Lisa Smit; Zoran Trogrlić; John W Devlin; Robert-Jan Osse; Huibert H Ponssen; Arjen J C Slooter; Nicole G M Hunfeld; Wim J R Rietdijk; Diederik Gommers; Mathieu van der Jagt Journal: BMJ Open Date: 2020-09-23 Impact factor: 2.692